Clinical Trials Browser

Interventional × Gastroesophageal Junction Adenocarcinoma × Paclitaxel × Clear all

NCT04656041 2025-11-14

Folfox+Irinotecan+Chemort In Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma

NCT02898077 2022-06-14

A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Phase 3 Completed

440 enrolled 19 charts

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma